(Q46003200)

18 December 2017

title

Open-label trial of atomoxetine hydrochloride in adults with ADHD. (English)

1 reference

18 December 2017

1 reference

5

Christopher Gillberg

1 reference

18 December 2017

Mats Johnson

1

1 reference

18 December 2017

Mats Cederlund

series ordinal

2

1 reference

18 December 2017

Maria Råstam

series ordinal

3

1 reference

18 December 2017

Björn Areskoug

series ordinal

4

1 reference

18 December 2017

publication date

20 May 2009

1 reference

18 December 2017

Journal of Attention Disorders

published in

1 reference

18 December 2017

volume

13

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

539-545

1 reference

18 December 2017

Functional outcomes in the treatment of adults with ADHD.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332372

Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332372

Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332372

The impact of ADHD and autism spectrum disorders on temperament, character, and personality development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332372

Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332372

The Asperger Syndrome (and high-functioning autism) Diagnostic Interview (ASDI): a preliminary study of a new structured clinical interview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332372

Assessing psychiatric impairment in primary care with the Sheehan Disability Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332372

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332372

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709332372

21 January 2018

Identifiers

DOI

10.1177/1087054709332372

1 reference

18 December 2017

release_pkfkuydu2ndl3ntcom7f3woiie

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pkfkuydu2ndl3ntcom7f3woiie

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

18 December 2017